Q4 2026 Shaily Engineering Plastics Ltd Earnings Call Transcript
Key Points
- Shaily Engineering Plastics Ltd (BOM:501423) achieved a significant milestone with the commercial launch of pen injectors for semaglutide in India and global markets, marking its entry into highly regulated pharmaceutical markets like Canada.
- The healthcare segment showed remarkable growth, with revenue doubling in Q4 FY26 and increasing by 139% for the full year, contributing 40% to the consolidated revenue.
- The company successfully commenced commercial supplies to a consumer electronics customer, marking a new growth vector in a high-complexity market.
- Shaily Engineering Plastics Ltd (BOM:501423) entered the semiconductor supply chain by signing a supply agreement with a Korean company, aligning with India's China Plus One policy.
- The company reported strong financial performance with a 26% year-on-year revenue growth, a 61% increase in EBITDA, and an 83% rise in PAT for FY26.
- Geopolitical uncertainties and global trade tensions impacted freight movement, supply chain, and input cost dynamics, leading to raw material price inflation.
- The consumer segment experienced a decline, with revenues down 9% for the full year, primarily due to weaker market demand for home furnishings in Europe and the US.
- Machine utilization, although improved, was still below optimal levels at 47.6% for FY26.
- The company faces challenges in scaling up new capacities, with current production lines running below optimal speed and efficiency.
- There is uncertainty regarding the timing of approvals and market launches in key geographies like Brazil, Turkey, and Mexico, which could impact future growth projections.
Ladies and gentlemen, good day, and welcome to the Q4 and FY26 earnings conference call of Shaily Engineering Plastics Limited. (Operator Instructions) Before we begin, a brief disclaimer.
This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call.
These statements are not the guarantees of future performance, and it may involve risks and uncertainties that are difficult to predict. I now hand the conference over to Mr. Amit Sanghvi, Managing Director of Shaily Engineering Plastics Limited.
Thank you, and over to you, sir. Thank you very much.
Good afternoon, and a very warm welcome to all the participants. I would like to thank you for joining us today for Shaily Engineering Plastics Q4 and FY26 earnings conference call. I have with me Mr. Sanjay Shah, our Chief Strategy Officer; and SGA, our Investor Relations advisers.
I hope everyone has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
